Differential assembly of mouse and human tumor microenvironments
Top Cited Papers
Open Access
- 19 May 2026
- journal article
- Published by Springer Nature in Nature Immunology
- Vol. 27 (6) , 1282-1293
Abstract
Mouse models are frequently used to develop treatments for human cancer. However, the degree to which their tumor microenvironments (TMEs) are synonymously assembled is particularly poorly characterized. Through systematic immunoprofiling of 15 commonly used mouse models, we found that most murine TMEs recapitulate the composition of poorly infiltrated human tumors, extensively biased toward high macrophage densities. We discovered substantial species-specific biases of chemokine expression networks known to drive TMEs assembly, together with discoordinated frequencies of T and myeloid cell subtypes. Even with variable alignment, conserved cell-type-specific gene expression programs emerged across species and cohorts. Dissecting the coordinated T cell–myeloid gene expression programs revealed a conserved axis between interferon-responsive myeloid states and ongoing T cell cytotoxicity that transcends tissue of origin and predicts clinical outcome. Collectively, this work provides a practical atlas outlining both the hazards and opportunities of using mice to model human cancer.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01CA197363)
- AbbVie
- Amgen
- Bristol-Myers Squibb
- Genentech
- Pfizer
- The UCSF ImmunoX HuMu CoProject funding (internal to UCSF) was obtained by MFK.
This publication has 85 references indexed in Scilit:
- The coming era of nudge drugs for cancerCancer Cell, 2025
- Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityCancer Cell, 2024
- The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsCancer Cell, 2023
- Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancerCancer Cell, 2022
- Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCCHepatology, 2022
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerCancer Cell, 2021
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapyCancer Cell, 2021
- Cell Detection with Star-Convex Polygons2018
- Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell TherapyCancer Cell, 2017
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityCancer Cell, 2014